Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid Nitrogen vs Vitamin D3 for Cutaneous Warts
NCT05739786Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- May 2022
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cholecalciferol in cutaneous warts, sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Effectiveness of liquid nitrogen and intralesional vitamin D3 in treatment of cutaneous warts at 9 weeks. Started May 2022; status: completed.
02
Drugs
cholecalciferol
03
Conditions
cutaneous warts
Beyond the preview
Go deeper on NCT05739786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05739786.